Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control

Author:

Rathjens Franziska S12,Blenkle Alica1ORCID,Iyer Lavanya M12,Renger Anke3,Syeda Fahima4,Noack Claudia12,Jungmann Andreas56,Dewenter Matthias67ORCID,Toischer Karl8,El-Armouche Ali9,Müller Oliver J10,Fabritz Larissa41112ORCID,Zimmermann Wolfram-Hubertus1213,Zelarayan Laura C12,Zafeiriou Maria-Patapia1213ORCID

Affiliation:

1. Institute of Pharmacology and Toxicology, University Medical Center, Goettingen, Germany

2. DZHK (German Center for Cardiovascular Disease), partner site, Goettingen, Germany

3. Institut für Erziehungswissenschaften, Humboldt University, Berlin, Germany

4. Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK

5. Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany

6. DZHK (German Center for Cardiovascular Disease), partner site Heidelberg/Mannheim, Germany

7. Department of Molecular Cardiology and Epigenetics, University of Heidelberg, Germany

8. Department of Cardiology and Pneumology, University Medical Center, Goettingen, Germany

9. Department of Pharmacology and Toxicology, Faculty of Medicine, University of Technology-Dresden, Germany

10. Department of Internal Medicine III, University of Kiel, Kiel, Germany

11. Division of Rhythmology, Department of Cardiovascular Medicine, Hospital of the University of Münster, Münster, Germany

12. University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

13. Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), University of Goettingen, Germany

Abstract

Abstract Aims  Arrhythmias and sudden cardiac death (SCD) occur commonly in patients with heart failure. We found T-box 5 (TBX5) dysregulated in ventricular myocardium from heart failure patients and thus we hypothesized that TBX5 reduction contributes to arrhythmia development in these patients. To understand the underlying mechanisms, we aimed to reveal the ventricular TBX5-dependent transcriptional network and further test the therapeutic potential of TBX5 level normalization in mice with documented arrhythmias. Methods and results  We used a mouse model of TBX5 conditional deletion in ventricular cardiomyocytes. Ventricular (v) TBX5 loss in mice resulted in mild cardiac dysfunction and arrhythmias and was associated with a high mortality rate (60%) due to SCD. Upon angiotensin stimulation, vTbx5KO mice showed exacerbated cardiac remodelling and dysfunction suggesting a cardioprotective role of TBX5. RNA-sequencing of a ventricular-specific TBX5KO mouse and TBX5 chromatin immunoprecipitation was used to dissect TBX5 transcriptional network in cardiac ventricular tissue. Overall, we identified 47 transcripts expressed under the control of TBX5, which may have contributed to the fatal arrhythmias in vTbx5KO mice. These included transcripts encoding for proteins implicated in cardiac conduction and contraction (Gja1, Kcnj5, Kcng2, Cacna1g, Chrm2), in cytoskeleton organization (Fstl4, Pdlim4, Emilin2, Cmya5), and cardiac protection upon stress (Fhl2, Gpr22, Fgf16). Interestingly, after TBX5 loss and arrhythmia development in vTbx5KO mice, TBX5 protein-level normalization by systemic adeno-associated-virus (AAV) 9 application, re-established TBX5-dependent transcriptome. Consequently, cardiac dysfunction was ameliorated and the propensity of arrhythmia occurrence was reduced. Conclusions  This study uncovers a novel cardioprotective role of TBX5 in the adult heart and provides preclinical evidence for the therapeutic value of TBX5 protein normalization in the control of arrhythmia.

Funder

University Medical Center Goettingen

German Foundation of Heart Research

German Center for Cardiovascular Disease

Deutsche Forschungsgemeinschaft

British Heart Foundation

Foundation Leducq

Germany’s Excellence Strategy

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3